PHARMACY BOARD OF AUSTRALIA and HAMILTON

In this matter, the Pharmacy Board of Australia initiated proceedings against a pharmacist, Hamilton, to address conduct occurring prior to the implementation of the Health Practitioner Regulation National Law. The case was heard by the Administrative Appeals Tribunal, where the Board sought a declaration that Hamilton's conduct constituted professional misconduct under the National Law, a cancellation of his registration, and an order for costs. The Tribunal was required to determine whether it was necessary to assess and characterise Hamilton's conduct, as well as impose a penalty, under the National Law or the corresponding prior Act, the Pharmacy Act 1964 (WA). Additionally, the Tribunal had to consider whether the proceedings could be initiated under an expired transitional provision, given that the Board had opened an 'own-motion notification' prior to the expiration of the transitional period.

The Tribunal concluded that it was necessary to assess Hamilton's conduct under the National Law. The Court found that the presumption against retrospective operation of statute was not rebutted, and the proceeding could not be commenced under the expired transitional provision. However, the Tribunal determined that the conduct in question, which involved dispensing anabolic androgenic steroids to patients for purposes that did not align with recognised therapeutic standards, in quantities and combinations that had the potential for misuse and abuse, and the dispensing of repeat authorisations and multiple prescriptions despite the known potential for misuse and abuse, constituted professional misconduct. The Tribunal found that Hamilton's conduct had the potential to cause an unacceptable hazard to the health of patients and others, and had the potential for dependency.

The Tribunal ordered that Hamilton's registration as a pharmacist be cancelled and declared that his conduct constituted professional misconduct. Additionally, the Tribunal ordered that Hamilton pay the costs of the proceeding. The decision highlights the importance of adhering to recognised therapeutic standards and the potential consequences of engaging in conduct that poses an unacceptable hazard to the health of patients and others.